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occasionally amoral individual physicians
and researchers. One such was Dr Albert M
Kligman." But this is to let off the hook the
checks and balances, the internal scrutinies
of a civilized society and of the professional
bodies within it.
Why did the prison system permit this
abuse of inmates? A late chapter reveals
that the cash paid to inmates as an
inducement to participate in the experiments
financed a system of homosexual rape and
prostitution within the jail. Why did the
Superintendent of the Philadelphia Prison
System, Edward Hendrick, "a tall, stern
public official with strong religious beliefs"
countenance such a thing? Why did the
pharmaceutical companies not just connive
at but actively finance these experiments
and the payments? Why did the medical
establishment in the USA not put an end to
the whole thing?
Jessica Mitford came to a very different
conclusion to Hornblum. By focusing on
the systemic, institutional and financial she
showed conclusively that this was more
than a couple of bad apples in the barrel. It
is from Jessica Mitford, rather than from
Allen Hornblum, that one learns that the
World Medical Association proposed as
long ago as 1961 that prisoners should not
be used in medical experiments but that
"the recommendation was never formally
adopted, largely because of the opposition
of American doctors".
It is the curse of American bioethics
that, like Lady Thatcher, it can see only
individuals and has no concept of society.
Allen Hornblum's is a necessary and
worthwhile book, but by writing
essentially a collection of individual
biographies rather than a work of history,
he fails even to ask the most important
question: when a great evil has been
done, where do the boundaries lie between
individual and collective guilt?
Tom Wilkie,
The Wellcome Trust
T A Ban, D Healy, E Shorter (eds), The
rise ofpsychopharmacology and the story of
the CINP, Budapest, Animula, 1998, pp. 448.
I started work as a medical practitioner
in 1952 before the introduction of any
modern psychotropic drugs, and began in
psychiatry in 1958 in a very large (3000-
bed), poorly staffed old-fashioned mental
hospital. As junior doctors we had great
responsibility. We now had chlorpromazine,
imipramine, chlordiazepoxide and related
drugs. ECT was widely used. I vividly recall
the impact of such drugs as patients, who
were cured or much improved, were
discharged. But of equal importance were
the changes in society; full employment;
social security benefits; and finally
government-provided accommodation at
affordable rents. We must also not forget
the change in psychiatrists' attitudes to
patients.
This volume is made up of reminiscences
of members of the Collegium. While I was
initially irritated by the self-congratulatory
tone (which was to be expected by the
format), I was fascinated by the accounts of
the pioneers in the field of psychotropic
drug therapy. How great was the part
played by serendipity how little inductive
science was used! Trial and error were and
are the name of the game. The book shows
that we lack an overall understanding of
how the brain is organized. As Joel Elkes
puts it (p. 20): "The good boot of
empiricism had propelled our field mightily
forward. New drugs were beckoning on the
horizon and facts were hunting for an
explanation. Yet the Science of it all was
sparse, a mere silhouette". Not that much
has changed.
The pharmacological industry's creditable
role is well described. It is salutary for
Anglo-Saxons to note that the effects of
chlorpromazine were discovered by Jean
Delay and Pierre Deniker in France, and
those of imipramine by Roland Kuhn in
Switzerland. (I enjoyed Kuhn's justification
for his dislike of double-blind controlled
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trials, as I have long felt them to be a
rationing device beloved of regulators who
need reassurance.) On another note, I felt
that many of the contributors may not have
appreciated the impact that mescaline and
LSD induced states had had on the
psychiatric "psyche" leading to the "shift in
the paradigm" facilitating the discovery of
psychotropic drugs.
The wide spread of the nationalities of
the members of the Collegium is impressive,
and their accounts show how universal are
science and clinical practice. Many of those
whose names come up in the book are well-
known researchers and authors, and their
personal histories brought to life for me the
intense excitement of the time when we
started to use modern drugs.
David Marjot,
Sunbury-on-Thames
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From the mid-nineteenth century,
sexuality and reproduction have become
biomedical subjects. In her long-awaited,
comprehensive monograph on the
emergence and evolution of scientific
approaches to human reproduction in
America from the early twentieth century to
the 1960s, Adele Clarke analyses important
sections of this history.
Central to Clarke's analysis is the
argument that the loosely defined group of
reproductive sciences have always had to
struggle with low and marginal status in the
scientific hierarchy- a position that Clarke,
not very satisfactorily, denotes in shorthand
as "illegitimacy"-and their pervasive
influence has been obscured by their
apparent marginality within the scientific
world. "My focus", says Clarke, "is on how
certain scientists in specific locales came to
envision a set of problems of reproductive
research, how they organized themselves to
work on those problems, and how they
interacted among themselves and with their
audiences, sponsors, and consumers to
sustain this research and develop it into a
recognized discipline" (p. 27). The so-called
reproductive sciences, she shows, were
constituted during a formative period in
American life sciences by the amalgamation
of forces stemming from the worlds of
biology, medicine, and agriculture, greatly
aided by the contemporaneous expansion of
American universities and research
institutions. These forces, in turn, existed in
an often creative state of tension with the
rather different worlds of birth control
activists and eugenicists.
Initially, scientists interested in
reproduction steered clear of socially
sensitive issues such as birth control,
focusing exclusively on basic physiological
research. The elucidation of the menstrual
cycles of laboratory animals, for instance,
was considered a truly scientific subject
while the development of a simple
contraceptive device was not. Similarly, the
study of human sexual behaviour and its
supposed aberrations was also left strictly
alone. In all this, the emerging science of
the endocrine secretions provided the
paradigm, which was influenced significantly
by the well-established embryological
orientation of American biology. Although,
as Clarke documents, the reputation of
endocrinology itself was rather dubious in
the earlier years of this century because of
its associations with matters such as
biological rejuvenation, it was still a
dazzling new science and eminently suited
to provide a scientific foundation for
reproductive biology. The establishment of
the reproductive sciences in America was
not, however, an exclusively intellectual
matter: as Clarke shows, the reproductive
sciences, despite their apparent marginality,
were remarkably successful in attracting
generous funding from sources such as the
Rockefeller Foundation and from the
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